Achilles Therapeutics Statistics
Total Valuation
BXMT has a market cap or net worth of $3.16 billion. The enterprise value is $19.39 billion.
Important Dates
The last earnings date was Wednesday, July 30, 2025, before market open.
| Earnings Date | Jul 30, 2025 |
| Ex-Dividend Date | Jun 30, 2025 |
Share Statistics
BXMT has 169.65 million shares outstanding. The number of shares has decreased by -0.36% in one year.
| Current Share Class | 169.65M |
| Shares Outstanding | 169.65M |
| Shares Change (YoY) | -0.36% |
| Shares Change (QoQ) | -0.06% |
| Owned by Insiders (%) | 1.20% |
| Owned by Institutions (%) | 60.09% |
| Float | 158.93M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 16.54 |
| PS Ratio | 13.61 |
| Forward PS | 6.68 |
| PB Ratio | 0.87 |
| P/TBV Ratio | 0.89 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 9.60 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 81.88 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 68.14, with a Debt / Equity ratio of 4.59.
| Current Ratio | 68.14 |
| Quick Ratio | 67.84 |
| Debt / Equity | 4.59 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -0.31%.
| Return on Equity (ROE) | -0.31% |
| Return on Assets (ROA) | -0.05% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BXMT has paid $1.78 million in taxes.
| Income Tax | 1.78M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +8.49% in the last 52 weeks. The beta is 1.16, so BXMT's price volatility has been higher than the market average.
| Beta (5Y) | 1.16 |
| 52-Week Price Change | +8.49% |
| 50-Day Moving Average | 19.31 |
| 200-Day Moving Average | 19.03 |
| Relative Strength Index (RSI) | 39.11 |
| Average Volume (20 Days) | 1,180,084 |
Short Selling Information
The latest short interest is 8.47 million, so 4.99% of the outstanding shares have been sold short.
| Short Interest | 8.47M |
| Short Previous Month | 10.22M |
| Short % of Shares Out | 4.99% |
| Short % of Float | 5.33% |
| Short Ratio (days to cover) | 6.35 |
Income Statement
In the last 12 months, BXMT had revenue of $236.80 million and -$12.58 million in losses. Loss per share was -$0.07.
| Revenue | 236.80M |
| Gross Profit | 236.80M |
| Operating Income | -2.53M |
| Pretax Income | -153.26M |
| Net Income | -12.58M |
| EBITDA | n/a |
| EBIT | n/a |
| Loss Per Share | -$0.07 |
Full Income StatementBalance Sheet
The company has $400.32 million in cash and $16.62 billion in debt, giving a net cash position of -$16.22 billion or -$95.64 per share.
| Cash & Cash Equivalents | 400.32M |
| Total Debt | 16.62B |
| Net Cash | -16.22B |
| Net Cash Per Share | -$95.64 |
| Equity (Book Value) | 3.62B |
| Book Value Per Share | 21.32 |
| Working Capital | 19.48B |
Full Balance SheetCash Flow
| Operating Cash Flow | 329.41M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 100.00%, with operating and profit margins of -1.07% and -5.31%.
| Gross Margin | 100.00% |
| Operating Margin | -1.07% |
| Pretax Margin | -4.24% |
| Profit Margin | -5.31% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of $1.88, which amounts to a dividend yield of 10.08%.
| Dividend Per Share | $1.88 |
| Dividend Yield | 10.08% |
| Dividend Growth (YoY) | -24.19% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.36% |
| Shareholder Yield | 10.44% |
| Earnings Yield | -0.40% |
| FCF Yield | n/a |
Dividend DetailsAnalyst Forecast
The average price target for BXMT is $20.00, which is 7.24% higher than the current price. The consensus rating is "Hold".
| Price Target | $20.00 |
| Price Target Difference | 7.24% |
| Analyst Consensus | Hold |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 7, 2013. It was a reverse split with a ratio of 1:10.
| Last Split Date | May 7, 2013 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |
